期刊文献+

蛋白酶体活性抑制对大鼠海马tau蛋白的泛素化影响 被引量:4

Effect of proteasome inhibition on the ubiquitination of tau protein
下载PDF
导出
摘要 目的:探讨蛋白酶体活性抑制对大鼠海马tau蛋白的泛素化影响。方法:利用双侧海马注射蛋白酶体的特异性抑制剂——乳胞素分别进行蛋白酶体活性检测、免疫印迹、免疫共沉淀,以检测大鼠海马内tau蛋白的泛素化改变情况。结果:(1)乳胞素引起蛋白酶体活性在24和48h较对照组明显下降;(2)免疫共沉淀结果显示,蛋白酶体活性抑制使tau蛋白发生了异常泛素化。结论:乳胞素抑制了蛋白酶体活性并导致了大鼠海马tau蛋白的异常泛素化。 Objective To investigate the effect of proteasome inhibition on the ubiquitination of tau protein. Methods We injected bilaterally lactaeystin, a specific inhibitor of proteasome, into the hippocampus of the rats and employed proteasome activity assay, Western blotting and eo-immunoprecipitation to observe the ubiquitination changes of tau protein in rats' hippoeampus. Results We observed the following results in our experiment: (1) Laetacystin obviously inhibited the ehymotrypsin-like activity of proteasome at the 24th h and the 48th h; (2) Proteasome inhibition increased the ubiquitination of tau. Conclusion Proteasome inhibition leads to abnormal ubiquitination of tau protein in rats' hippoeampus.
出处 《实用医学杂志》 CAS 北大核心 2011年第3期386-389,共4页 The Journal of Practical Medicine
基金 国家自然科学基金项目(编号:30901806) 广东省自然科学基金项目(编号:9451018201003650)
关键词 阿尔茨海默病 乳胞素 蛋白酶体 TAU蛋白 泛素化 Alzheimer disease Laetaeystin Proteasome Tau protein Ubiquitination
  • 相关文献

参考文献8

  • 1Oddo S. The ubiquitin-proteasome system in Alzheimer's disease [J]. J Cell Mol Med, 2008, 12(2):363-373.
  • 2陈晶波,徐向进.泛素-蛋白酶体途径、代谢异常与2型糖尿病及其血管并发症[J].实用医学杂志,2008,24(3):488-490. 被引量:2
  • 3Hegde A N, Upadhya S C. The ubiquitin-proteasome pathway in health and disease of the nervous system [J].Trends Neurosci, 2007,30(11):587-595.
  • 4Miwa H, Kubo T, Suzuki A, et al. Retrograde dopaminergic neuron degeneration following intrastriatal proteasome inhibition [J].Neurosci Lett, 2005,380(1-2):93-98.
  • 5Ren Q G, I,iao X M, Wang Z F, et al. The involvement of glycogen synthase kinase-3 and protein phosphatase-2A in lactacystin-induced tau accumulation [J]. FEBS Lett, 2006, 580(10) : 2503-2511.
  • 6Delobel P, Leroy O, Hamdane M, et al. Proteasome inhibition and Tau proteolysis: an unexpected regulation [J]. FEBS Lett, 2005, 579(1 ) : 1-5.
  • 7Yew E H, Cheung N S, Chov M S, et al. Proteasome inhibition by lactacystin in primary neuronal cells induces both potentially neuroprotective and pro-apoptotic transcriptional responses: a microarray analysis [J]. J Neurochem, 2005,94 (4) : 943-956.
  • 8de Vrij F M, Fischer D F, van Leeuwen F W, et al. Protein quality control in Alzheimer' s disease hy the ubiquitin proteasome system [J]. Prog Neurubiol, 2004,74 (5):249- 270.

二级参考文献24

  • 1叶彦,欧阳静萍,王保华,李柯,刘敏,杨海,鹭徐怡.IRS-1的表达和泛素化在KKAy及C57BL/6J小鼠糖尿病发展过程中的意义[J].武汉大学学报(医学版),2006,27(3):279-282. 被引量:7
  • 2Meiners S, Laule M, Rother W, et al. Ubiqultin-proteasome pathway as a new target for the prevention of restenosis [J]. Circulation, 2002, 105 (4) : 483 -489.
  • 3Qiu w, Kohen Avramoglu R, Mhapsekar S, et al. Glucosamine-induced endoplasmic reticulum stress promotes ApoB 100 degradation: evidence for Grp78-mediated targeting to proteasomal degradation [J]. Artefioscler Thromb Vasc Biol,2005,25 (3):571-577.
  • 4Kuhn D J,Burns A C,Kazi A,et al. Direct inhibition of the ubiquitin-proteasome pathway by ester bond-containing green tea polyphenols is associated with increased expression of sterol regulatory elementbinding protein 2 and LDL receptor [J]. Biochim Biophys Acta,2004, 1682(1-3) : 1-10.
  • 5AkarsuE, PirimI, Capolug I, et al. Relationship between electroneurographic changes and serum ubiquitin levels in patients with type 2diabetes [J]. Diabetes Care,2001, 24(1):100-103.
  • 6Adachi Uehara N,Kato M,Nimura Y,et al. Up-regulation of genes for oxidative phosphorylation and protein turnover in diabetic mouse retina [J]. Exp Eye Res, 2006,83 (4) 849-857.
  • 7Rui L,Yuan M, Frantz D, et al. SOCS- 1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2 [J]. J Biol Chem,2002,277 (44) : 42394-42398.
  • 8Rome S, Meugnier E, Vidal H. The ubiquitin-proteasome pathway is a new partner for the control of insulin signaling [J]. Curr Opin Clin Nutr Metab Care, 2004,7(3) :249-254.
  • 9Juan C M,Samuel G. Waring,adrian cooper, nigel turner, ross laybutt : casitas blineage lymphoma-deilcient mice are protected against high-fat diet-induced obesity and insulin resistance [J]. Diabetes, 2006,55 ( 3 ) : 708-715.
  • 10Yu C,Chen Y,Cline G W,et al. Mechanismby which fatty acids inhibit insulin activation of insulin receptor substrate- 1 ( IRS- 1 )-associated phosphati- dylinositol3-kinase activity in tousle [J].J Biol Chem, 2002,277 (52) : 50230-50236.

共引文献1

同被引文献19

引证文献4

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部